TOR2A
Torsin-2A
Also known as: FLJ14771, TOR2A_HUMAN, TORP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JU69
- Gene
- TOR2A
- Ensembl
- ENSG00000160404
- Chromosome
- 9
- Canonical length
- 321 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Endoplasmic reticulum,Plasma membrane
- Secretome location
- Secreted to blood
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
This gene encodes a member of the AAA family of adenosine triphosphatases with similarity to Clp proteases and heat shock proteins. Alternative splicing at this locus results in the translation of multiple isoforms of the encoded protein, some of which contain salusin peptides in the C-terminal region. These peptides may play roles in hypotension, myocardial growth and the induction of mitogenesis, and may also be involved in the pathogenesis of atherosclerosis. The antimicrobial peptide salusin-beta has antibacterial activity. [provided by RefSeq, Nov 2014]
Canonical amino-acid sequenceUniProt
321 residues, UniProt reviewed canonical sequence.
>Q5JU69|TOR2A
1 MAAATRGCRP WGSLLGLLGL VSAAAAAWDL ASLRCTLGAF CECDFRPDLP GLECDLAQHL
61 AGQHLAKALV VKALKAFVRD PAPTKPLVLS LHGWTGTGKS YVSSLLAHYL FQGGLRSPRV
121 HHFSPVLHFP HPSHIERYKK DLKSWVQGNL TACGRSLFLF DEMDKMPPGL MEVLRPFLGS
181 SWVVYGTNYR KAIFIFISNT GGKQINQVAL EAWRSRRDRE EILLQELEPV ISRAVLDNPH
241 HGFSNSGIME ERLLDAVVPF LPLQRHHVRH CVLNELAQLG LEPRDEVVQA VLDSTTFFPE
301 DEQLFSSNGC KTVASRIAFF LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TOR2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 25 nTPM
- spleen: 20 nTPM
- testis: 20 nTPM
- cerebellum: 15 nTPM
- liver: 14 nTPM
- pancreas: 13 nTPM
Single-cell type
- late primary spermatocytes: 83 nCPM
- hofbauer cells: 77 nCPM
- early spermatids: 70 nCPM
- syncytiotrophoblasts: 60 nCPM
- extravillous trophoblasts: 49 nCPM
- cytotrophoblasts: 46 nCPM
Immune cell
- eosinophil: 97 nTPM
- intermediate monocyte: 80 nTPM
- non-classical monocyte: 79 nTPM
- myeloid DC: 72 nTPM
- classical monocyte: 69 nTPM
- neutrophil: 44 nTPM
Brain region
- cerebral cortex: 7.3 nTPM
- thalamus: 7 nTPM
- amygdala: 6.7 nTPM
- choroid plexus: 6.4 nTPM
- cerebellum: 6.1 nTPM
- medulla oblongata: 6.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TOR2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TOR2A as an antibody target. Whether an autoantibody or antibody against TOR2A could matter depends on whether native TOR2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TOR2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TOR2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...